Workflow
AI医疗服务
icon
Search documents
微医控股三闯港交所:净利连亏三年,毛利率波动大且呈下降趋势
9月29日,根据港交所最新公告,微医控股有限公司(简称"微医控股")更新招股书,披露截至2025年6 月30日的最新业绩,继续推进其在联交所的IPO申请进程。 值得一提的是,微医控股曾在2021年4月以及2024年12月先后向港交所提交招股书。此次已是该公司第 三次赴港交所"闯关"。 2010年创立的微医,最初只是一个挂号网站。经过15年发展,它已构建起覆盖在线诊疗、健康管理、医 保控费的完整生态。截至2024年6月,微医连接1.15万家医疗机构、31.8万名医生,服务2.6亿注册用 户,在天津等地打造的"数字健共体"模式,通过AI技术实现医保基金高效利用,糖尿病患者糖化血红蛋 白达标率从17.8%提升至44.2%。 微医控股主要拥有AI医疗服务和线上线下医疗服务两大核心业务。在AI医疗服务领域,以健共体为依 托,采用以签约人员为基础的打包付费模式。公共医疗保险基金设定年度预算,微医与其他健共体参与 者按约定比例分享盈余或分摊亏损。例如在天津,不仅提供健康管理会员服务、云药房服务,还通过增 值服务满足多样化需求。线上线下医疗服务则从免费线上预约系统起步,发展为线上线下融合的诊疗模 式,为个人和企业客户提供全方 ...
AI医疗“运营商”突围:微医控股半年营收30.8亿,现金流转正
Xin Lang Zheng Quan· 2025-10-08 04:19
Core Insights - The core viewpoint of the articles is that WeDoctor Holdings is undergoing a strategic transformation from scale expansion to quality growth, driven by significant revenue increases and improvements in key financial metrics, particularly in AI-driven healthcare services [1][2][4]. Financial Performance - In the first half of 2025, WeDoctor Holdings reported revenue of 3.08 billion yuan, a year-on-year increase of 69.4% [1]. - The company achieved a compound annual growth rate (CAGR) of 100.5% in its continuing operations revenue from 2022 to 2024, with revenues of 1.368 billion yuan, 1.863 billion yuan, and 5.496 billion yuan respectively [2]. - The adjusted loss rate for continuing operations narrowed from 7.0% in the same period last year to 4.2% in the first half of 2025, indicating a move towards breakeven [4]. AI Healthcare Services - AI healthcare service revenue has become the dominant revenue stream, accounting for 92.2% of total revenue in the first half of 2025, up from 79.2% in the first half of 2024 [2]. - The revenue from AI healthcare services grew significantly, from 628 million yuan in 2022 to 4.806 billion yuan in 2024, with a year-on-year growth of 97.3% in the first half of 2025 [2]. Health Management Services - Health management membership services saw explosive growth, with revenue increasing nearly tenfold from 354 million yuan in 2023 to 3.893 billion yuan in 2024, and reaching 2.389 billion yuan in the first half of 2025, a growth rate of 131.4% [4]. - The number of health management members expanded from 110,000 in 2022 to approximately 1.1 million by mid-2025, demonstrating the scalability of the model [8]. Operational Efficiency - The implementation of AI technology has significantly improved operational efficiency, with the average number of patients managed by a health manager increasing from about 580 in 2022 to 2,600 in the first half of 2025, a nearly 4.5-fold increase [6]. - The effectiveness of healthcare management has also improved, with blood pressure control rates for various patient groups showing significant increases from June 2024 to June 2025 [6]. Business Model Transformation - WeDoctor Holdings has shifted from providing standalone hardware to an AI-driven value-based healthcare model, restructuring the entire healthcare service chain [5]. - The innovative health community model is being replicated across multiple cities, including Shanghai, Wenzhou, Hangzhou, Chongqing, and Nanjing, indicating the model's potential for nationwide expansion [8].
微医控股更新招股书,上半年营收同比增长69.4%
9月29日,微医控股在港交所平台更新招股书,披露截至2025年6月30日的最新业绩。2025年上半年,公 司实现营收30.8亿元,同比增长69.4%;其中AI医疗服务收入28.41亿元,同比增长97.3%,占总收入比 重超九成。 AI医疗服务收入占比超九成 微医控股是采用以签约人员为基础的打包付费模式运营健共体AI医疗健康服务的先驱。根据弗若斯特 沙利文的数据,按2024年收入计算,公司在中国数字健康服务市场(不包括药品销售)及AI医疗健康解决 方案市场均排名第一。 公司的业务由AI医疗服务与线上线下(300959)医疗服务两大板块组成。公司在天津的AI医疗服务主 要包括健康管理会员服务、云药房及增值服务。 微医控股于2015年创办中国首家互联网医院及2020年与天津市政府合作共同开发出健共体。健共体为一 种可推进家庭医生制度并通过与上级医院的合作强化基层医疗的新合作模式。公司为健共体构建了完善 的数字基础设施(包括云药房平台),扩大了机构间药品目录并提升了基层医疗机构的服务能力。随后, 公司在天津全市基层医疗机构设立慢病管理中心,初步专注于糖尿病领域;2022年推出以签约人员为基 础的打包付费模式,在该模式 ...
微医控股更新招股书 2025上半年营收同比增长69.4%
Zheng Quan Ri Bao Wang· 2025-09-30 03:16
这一AI赋能的整合医疗服务模式,不仅有效提升了成本效益与会员黏性,推动微医控股自身业务快速 增长,也为基层医疗机构提升服务水平、公共医疗保险基金优化支出带来了切实收益。从运营成效来 看,2024年6月至2025年6月,天津健共体内患者多项疾病管理指标显著提升,且全病种健康管理盈余率 由2024年的3.3%提升至2025年上半年的6.1%。 目前,该AI健共体模式正向上海、杭州、重庆、南京、深圳、温州、银川等多地复制推广。 随着AI技术的广泛深入应用,微医控股运营效率进一步提升。财务数据显示,2025年上半年,公司持 续经营业务经调整亏损率由去年同期的7.0%收窄至4.2%,并且公司实现了经营现金流首次转正。 微医控股AI医疗服务收入的显著增长,主要得益于健康管理会员服务的迅速放量。2024年度该部分收 入达38.93亿元,较2023年的3.54亿元增长近10倍;2025年上半年继续保持高增长,实现收入23.89亿 元,较2024年上半年的10.32亿元增长131.4%。截至2025年6月30日,健康管理会员服务已覆盖约110万 名健康会员。 招股书显示,微医控股通过AI驱动的价值医疗服务患者,在患者健康改善的 ...
微医控股更新招股书:上半年营收超30亿元并接近盈利,经营现金流首次转正
IPO早知道· 2025-09-30 00:23
从收入构成来看, AI医疗服务已成为 微医控股 核心增长引擎 —— 2022年至2024年 ,微医控股 AI医疗服务收入分别为6.28亿元、10.24亿元 和 48.06亿元 ; 今年上半年,微医控股 AI医疗服务 收入 从 2024年同期的 14.4亿元 增加 97.3% 至 28.41亿元 。而 在营收占比上, 今年上半年 AI 医疗服务占总营收 的比例已从 2024年同期的 79.2%进一步攀升至92.2% 。 今年上半年,微医控股AI医疗服务的收入占比进一步攀升至92.2%。 本文为IPO早知道原创 作者| Stone Jin 微信公众号|ipozaozhidao 据 IPO早知道消息, 微医控股有限公司 (以下简称 " 微医控股 ")于2025年9月29日更新招股 书,继续推进港交所主板上市进程,招银国际和华泰国际担任联席保荐人。 成立于 2004年的 微医控股 旗下现拥有 AI医疗服务 和 线上线下医疗服务 两大业务板块。 根据弗 若斯特沙利文的资料,按 2024年收入 计算 ,微医控股在中国数字健康服务市场(不包括药品销 售)及 AI医疗健康解决方案市场均排名第一。 根据最新版本的招股书披露,微 ...
微医控股:2025年上半年营收30.8亿元 AI医疗服务收入超九成
Zhi Tong Cai Jing· 2025-09-29 15:53
9月29日,微医控股最新业绩显示,2025年上半年公司营收30.8亿元,同比增长69.4%;其中AI医疗服务 收入达28.41亿元,同比大幅增长97.3%,占整体收入比重超过九成。 据弗若斯特沙利文报告,按2024年收入统计,微医控股在中国数字健康服务市场及AI医疗健康解决方 案市场中均位列第一。 根据当日微医控股向港交所递交的招股书披露,2022年、2023年及2024年,微医控股持续经营业务收入 分别为13.68亿元、18.63亿元和54.96亿元,年均复合增长率超过100%。 ...
去年全国互联网医院达3756所、诊疗1.3亿人次 AI医疗服务已有上市公司盈利
Mei Ri Jing Ji Xin Wen· 2025-09-19 09:20
Core Insights - The number of internet hospitals in China reached 3,756 last year, with a total of 130 million patient visits, indicating significant growth in the sector [1][4] - The integration of AI technology has improved the efficiency of online consultations, allowing doctors to manage their time better and enhance patient care [3][6] - Companies like Ping An Good Doctor and JD Health reported profitability in the first half of this year, reflecting a positive trend in the internet healthcare industry [6] Group 1: Industry Growth - The internet healthcare sector has seen a surge in patient numbers, particularly among chronic disease patients who benefit from online consultations [5][6] - The convenience of internet hospitals allows patients to send medical reports in advance, reducing the need for travel to major cities for consultations [1][3] Group 2: AI Integration - AI technology is being utilized to streamline the online consultation process, with platforms providing "personal AI assistants" to help doctors prepare for patient interactions [3][6] - The use of AI has reportedly increased service efficiency by 33%, saving doctors approximately 60,000 hours of work [3] Group 3: Chronic Disease Management - Chronic disease management is a key focus for internet hospitals, with platforms enhancing patient adherence to treatment through reminders and follow-ups [6][7] - The ability to provide medication delivery services is particularly beneficial for patients in remote areas, improving access to necessary treatments [3][6]
微医控股拟赴港上市 CEO张君简历没写其它学历 难道只有高中学历?
Xin Lang Cai Jing· 2025-09-18 06:15
来源:运营商财经网 运营商财经网 实习生郑永杰/文 作为知名的AI医疗健康解决方案提供商,微医一直以来收到广泛关注。去年年底微医正式向港交所交 递招股书,拟赴港上市。具体情况是怎样呢? 据招股书显示,微医控股在2021年至2023年的收入分别为9.62亿元、13.68亿元和18.63亿元,2024年上 半年收入达到18.18亿元,同比增长107.4%。公司经调整亏损率从2021年的140.8%降至2023年的27.1%, 2024年上半年进一步降至7.0%,亏损大幅收窄,接近盈利。 不过,微医控股的上市之路屡受打击。 2025年4月,证监会国际司对微医控股出具补充材料要求,重点关注廖杰远的历史违规情况及其实际控 制人认定问题。 微医控股在招股书中表示,廖杰远已承诺放弃其所持股份的所有投票权,且不在集团内担任任何职务。 这还要回溯到2022年7月,中国证监会公布行政处罚,微医控股集团因未依法及时披露持有易联众股份 变动情况且有误导性陈述,以及在限制转让期交易易联众股票等问题,被处以3030万元罚款,对创始人 廖杰远处以8万元罚款。 据证监会调查,2018年10月9日至2019年3月28日期间,微医集团利用多个证 ...
蚂蚁集团CEO韩歆毅:AI无法替代医生,更应该是医生的助手
Bei Ke Cai Jing· 2025-09-11 11:36
Core Viewpoint - Ant Group's CEO, Han Xinyi, emphasized that AI will not replace doctors in the foreseeable future but should serve as an assistant to enhance their capabilities [1] Group 1: AI in Healthcare - Ant Group is committed to using AI to support doctors, helping specialists expand their capabilities towards becoming general practitioners [1] - The company has established a medical health laboratory to explore AI-enabled multidisciplinary team (MDT) consultations [1] - Han stated that the only viable path for AI in healthcare is through human-machine collaboration [1] Group 2: Challenges in AI Medical Implementation - Han identified three core challenges in the implementation of AI in healthcare: high-quality data, suppressing hallucinations, and medical ethics [1] - High-quality data is fundamental, with costs for data labeling and training potentially exceeding hundreds of dollars per data point, requiring involvement from senior medical experts [1] - Suppressing hallucinations while maintaining model performance is a significant challenge, necessitating a balance between reducing errors and preserving service capability [1] - Ant Group has established a medical ethics advisory committee to explore regulations in this previously unaddressed area [1] Group 3: Market Focus and Strategy - Despite the healthcare market being valued at trillions, Ant Group is not in a rush to commercialize its AI healthcare solutions in the coming years [1] - The company aims to focus on accumulating professional data, suppressing model hallucinations, and building medical ethics frameworks [1] - Han believes that as long as the services are professional and trustworthy, users will naturally engage with them [1]
德生科技:AI产品主要布局政务、就业、医疗等核心民生服务领域
Sou Hu Cai Jing· 2025-08-22 04:02
Core Viewpoint - The company, Desheng Technology, is focusing on AI product development in key public service areas such as government affairs, employment, and healthcare [1] Group 1: AI Product Areas - The company's AI products are primarily deployed in government services, employment services, and healthcare [1] - Key products include AI government services that create a smart government service network for social security inquiries, policy interpretation, and business processing [1] - AI employment services aim to establish local employment service stations and a 15-minute employment service circle for precise matching of supply and demand [1] - AI healthcare services utilize "seamless payment" as an entry point to provide targeted health services based on user payment profiles [1] Group 2: Technological Integration - The company is integrating high-quality large models and computing power into its AI product iterations [1] - The goal is to connect B-end services to build a public service ecosystem [1]